Literature DB >> 2556614

Dextromethorphan and sigma ligands: common sites but diverse effects.

J M Musacchio1, M Klein, P D Canoll.   

Abstract

There is increasing evidence that sigma ligands and dextromethorphan (DM) bind to at least one common high-affinity site. DM and other antitussives do not produce psychotomimetic effects. This suggested that sigma ligands may produce their characteristic effects through another site, and prompted us to review critically the literature on the side effects of sigma opiates. Contrary to what is generally accepted, the dysphoric and psychotomimetic side effects of sigma opiates are mediated by the levo-and not by the dextrorotatory isomers. Moreover, these effects are unequivocally naloxone-reversible. Therefore, the current version of the "sigma receptor", with high affinity for the dextrorotatory sigma opiates, cannot explain the psychotomimetic effects of the levorotatory enantiomers. Thus, neither the "sigma ligands" nor its newly defined "receptor" are involved in the psychotomimetic effects of sigma opiates. Further experimentation with more selective drugs and with a combination of different methods will be necessary to identify the different binding sites, and to establish their physiological role and therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556614     DOI: 10.1016/0024-3205(89)90510-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Authors:  Kerri A Schoedel; Laura E Pope; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

2.  Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice.

Authors:  D J Sanger; D Joly
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.

Authors:  Edward D Levin; Corrine Wells; Susan Slade; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2018-01-31       Impact factor: 3.533

4.  Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex.

Authors:  Bahar Salavati; Tarek K Rajji; Reza Zomorrodi; Daniel M Blumberger; Robert Chen; Bruce G Pollock; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2017-05-29       Impact factor: 7.853

Review 5.  Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

Authors:  G Debonnel
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

Review 6.  NMDA receptor modulators: an updated patent review (2013-2014).

Authors:  Katie L Strong; Yao Jing; Anthony R Prosser; Stephen F Traynelis; Dennis C Liotta
Journal:  Expert Opin Ther Pat       Date:  2014-10-29       Impact factor: 6.674

7.  Sigma binding in a human neuroblastoma cell line.

Authors:  J Ryan-Moro; C C Chien; K M Standifer; G W Pasternak
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

8.  (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.

Authors:  J R Kahoun; A E Ruoho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 9.  Dextromethorphan. An overview of safety issues.

Authors:  J L Bem; R Peck
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

10.  A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteers.

Authors:  Laura E Pope; Kerri A Schoedel; Cynthia Bartlett; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.